Could GLP-1 Therapy in Bryn Mawr PA Bring You the Long-Term Weight Loss You Have Been Fighting For?
The average person can gain weight without even trying. Losing weight, on the other hand…not so much. Sadly, the $33 billion weight loss business has provided consumers with a lot of hoopla but little in the way of practical results. But now, everything might change. It’s all about the GLP-1 Therapy in Bryn Mawr PA, which has brought some interesting and exciting results.
What is GLP-1 Therapy in Bryn Mawr PA?
Semaglutide is an analogue to “glucagon-like peptide-1” (also known as GLP-1), and it’s taken weekly as a subcutaneous injection. It also has an impact on how slowly your stomach will empty during the digestion process.
The initial approval and use of GLP-1 Therapy in Bryn Mawr PA was for type 2 diabetes. It didn’t take long for researchers to identify a beneficial side effect, though: weight loss. Semaglutide users dropped an average of more than 12% of their body weight, according to drug trials. In fact, one in three lost more than 20% of their body weight.
What Are the Side Effects of GLP-1 Therapy in Bryn Mawr PA?
Semaglutide can have some side effects, including nausea, diarrhea, constipation, and fatigue. That said, these side effects were largely resolved by simply adjusting the dosage. Remember that up until this moment, the only medical treatment with comparable outcomes was bariatric surgery. Semaglutide is a safer alternative to bariatric surgery due to the fact that it bariatric surgery involves a major surgery.
The Numbers Speak for Themselves When it Comes to GLP-1 Therapy in Bryn Mawr PA
If you think that everything you’re read up until now sounds too good to be true, you are not alone. It makes one wonder: Does semaglutide live up to its publicity? Following are some verified outcomes from semaglutide drug testing. In a study to assess the efficacy of various semaglutide dosages, participants lost up to 16.2% of their body weight over the course of 52 weeks (as a percentage of their initial body weight). On average, participants lost 37 pounds of weight, a 12.4% reduction in their body weight.
In a trial that incorporated dietary and lifestyle modifications, the placebo group lost 2.4% of their body weight, compared to the semaglutide group, who lost 15-20%.
Being Overweight Comes with Many Complications
A person’s health is seriously impacted by being overweight. Specific examples include type 2 diabetes, high blood pressure, high cholesterol (especially LDL or “bad” cholesterol), heart disease and stroke, fatty liver and gallbladder disease, cancer (especially breast and colon cancer), sleep apnea, arthritis (especially in weight-bearing joints), and lower back pain.
Are You Having Trouble Losing Weight?
Do you want to know if GLP-1 Therapy in Bryn Mawr PA can be the best choice for you? It’s easy to find out additional information. For a free consultation, call 800-859-7511 or use our online contact form.